By Michael Erman (Reuters) on 10 June 2025.
Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.
President Donald Trump issued an executive order last month directing drugmakers to lower the prices of their medicines to align with what other countries pay.
According to the order, the administration was to set “Most Favored Nation” price targets within 30 days. The Department of Health and Human Services has said it expects drugmakers in the U.S. to set prices for their products at the lowest price paid by other high-income countries.
Read more here
Leave a Reply
You must be logged in to post a comment.